Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules-Reference-Cited by-同舟云学术

Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules

Published:2010-12 Issue:8 Volume:12 Page:982-991
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Kadam Sachin S.,Sudhakar M.,Nair Prabha D.,Bhonde Ramesh R.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference31 articles.

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004

2. Type 1 diabetes;Daneman;Lancet,2006

3. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen;Shapiro;New Engl J Med,2000

4. Science, medicine, and the future: islet and stem cell transplantation for treating diabetes;Serup;Br Med J,2001

5. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells;Ramiya;Nature Med,2000

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges;Endocrine;2024-05-10

2. Encapsulation of stem-cell derived β-cells: A promising approach for the treatment for type 1 diabetes mellitus;Journal of Colloid and Interface Science;2023-04

3. A Mini-Review of Current Treatment Approaches and Gene Therapy as Potential Interventions for Diabetes Mellitus Types 1;Advanced Biomedical Research;2023

4. Perinatal Stem Cell Therapy to Treat Type 1 Diabetes Mellitus: A Never-Say-Die Story of Differentiation and Immunomodulation;International Journal of Molecular Sciences;2022-11-23

5. Type 1 diabetes and engineering enhanced islet transplantation;Advanced Drug Delivery Reviews;2022-10